Kenneth C Jackson
Affiliation: University of Utah
- Pharmacotherapy for neuropathic painKenneth C Jackson
Pharmacotherapy Outcomes Research Center, Department of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City, Utah 84108, USA
Pain Pract 6:27-33. 2006..In refractory patients, combination therapy using two agents with synergistic mechanisms of action may offer greater pain relief without compromising the side-effect profile of each agent...
- Pharmacotherapy in lower back painKenneth C Jackson
Pain and Palliative Care, University Hospital and College of Pharmacy, University of Utah Health Sciences Center, Salt Lake City, Utah 84132, USA
Drugs Today (Barc) 40:765-72. 2004..More critical research is needed to further define the roles of these medications in treating pain associated with lower back injury...
- Assessment of adherence, persistence, and costs among valsartan and hydrochlorothiazide retrospective cohorts in free-and fixed-dose combinationsDiana I Brixner
University of Utah College of Pharmacy, Salt Lake City, UT 84112, USA
Curr Med Res Opin 24:2597-607. 2008....
- Economic evaluations in pain management: principles and methodsCarl V Asche
Pharmacotherapy Outcomes Research Center, Department of Pharmacotherapy, University of Utah College of Pharmacy, 421 Wakara Way, Suite 208, Salt Lake City, UT 84108, USA
J Pain Palliat Care Pharmacother 20:15-23. 2006....
- Persistent pain management for improved quality of lifeKenneth C Jackson
Texas Tech University Health Sciences Center, Lubbock
J Am Pharm Assoc (2003) 43:S30-1. 2003..To provide better care for patients with persistent pain, health care providers should educate themselves about the distinctions among addiction, physical dependence, pseudoaddiction, tolerance, and pseudotolerance...
- Clinician beliefs about opioid use and barriers in chronic nonmalignant painPaula H Grahmann
Texas Tech University School of Pharmacy, International Pain Center, Texas Tech Medical Center, 2319 81st Street, Lubbock, TX 79423, USA
J Pain Palliat Care Pharmacother 18:7-28. 2004..Opioids were most consistently accepted for sickle cell disease pain and least commonly endorsed for headaches, myofascial pain, and fibromyalgia. Factors that may influence clinicians' perceptions about opioids are discussed...
- Anticipating and treating opioid-associated adverse effectsChristopher M Herndon
Ortho McNeil, Division of Clinical Affairs, O Fallon, IL 62269, USA
Expert Opin Drug Saf 2:305-19. 2003..These adverse events, ranging from nuisance to therapy-limiting, are manageable when addressed quickly and appropriately. Opioids are safe and efficacious analgesics when these effects are considered...
- Role of corticosteroids in palliative careAllen Shih
Good Samaritan Hospital, 407 14th Ave SE, Payallup, WA, USA
J Pain Palliat Care Pharmacother 21:69-76. 2007..In the setting of palliative care, glucocorticoids have many uses, including many symptoms of malignancy, nausea, vomiting, depression, fatigue, anorexia and cachexia...
- Adherence with multiple-combination antihypertensive pharmacotherapies in a US managed care databaseKenneth C Jackson
Clin Ther 30:1558-63. 2008..These findings suggest patient compliance improves with simplified pharmacotherapeutic approaches...
- Management of opioid-induced gastrointestinal effects in patients receiving palliative careChristopher M Herndon
School of Pharmacy, Texas Tech University Health Sciences Center, Lubbock, USA
Pharmacotherapy 22:240-50. 2002..Common agents administered for nausea are butyrophenones, phenothiazines, metoclopramide, and serotonin-receptor antagonists. Those given to manage constipation are stimulant laxatives and stool softeners, individually or in combination...